CINECA IRIS Institutional Research Information System

GIAJ LEVRA, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.946
AS - Asia 952
EU - Europa 930
SA - Sud America 33
OC - Oceania 26
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.886
CN - Cina 486
IT - Italia 161
IE - Irlanda 118
GB - Regno Unito 106
DE - Germania 98
SG - Singapore 92
FR - Francia 87
SE - Svezia 76
IN - India 70
TR - Turchia 68
JP - Giappone 62
KR - Corea 60
FI - Finlandia 51
CA - Canada 50
PL - Polonia 46
VN - Vietnam 38
NL - Olanda 32
UA - Ucraina 28
ES - Italia 27
AU - Australia 25
TW - Taiwan 23
BE - Belgio 20
ID - Indonesia 18
BR - Brasile 15
HK - Hong Kong 13
CH - Svizzera 12
DK - Danimarca 9
RU - Federazione Russa 9
CZ - Repubblica Ceca 8
MX - Messico 8
PT - Portogallo 8
PE - Perù 7
AR - Argentina 6
AT - Austria 6
IL - Israele 6
RO - Romania 5
HU - Ungheria 4
LT - Lituania 4
RS - Serbia 4
AP - ???statistics.table.value.countryCode.AP??? 3
GR - Grecia 3
MY - Malesia 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
EG - Egitto 2
GT - Guatemala 2
IR - Iran 2
NO - Norvegia 2
TH - Thailandia 2
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
IQ - Iraq 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.895
Salva come PNG Salva come JPEG
Città #
Beijing 168
Chandler 149
Fairfield 129
Dublin 118
Houston 105
Redwood City 101
Ashburn 81
Singapore 76
Wilmington 75
Woodbridge 63
Cambridge 56
Shanghai 52
Ann Arbor 51
Seattle 49
Torino 43
Princeton 40
Medford 37
Nyköping 36
Guangzhou 32
Jacksonville 30
Pisa 28
Villeurbanne 28
Warsaw 28
Dong Ket 23
Nutley 21
Duncan 20
Dearborn 19
Jinan 17
Nanjing 17
Taipei 16
Jakarta 15
New York 14
Tianjin 14
Tokyo 14
Zhengzhou 14
Chengdu 13
Hangzhou 12
Paris 12
San Diego 12
Santa Clara 12
Boardman 11
Chicago 11
Darmstadt 11
Milan 11
Toronto 11
Boston 10
Central 10
Liverpool 10
Ottawa 10
London 9
New Delhi 9
Wuhan 8
Berlin 7
Brussels 7
Lima 7
Morgantown 7
Pune 7
Rome 7
Seongnam 7
Seoul 7
Shenyang 7
Utrecht 7
Chongqing 6
Fontenay-sous-bois 6
Tarrytown 6
Xian 6
Asnières 5
Baltimore 5
Chennai 5
Columbus 5
Davis 5
Frankfurt Am Main 5
Guiyang 5
Hefei 5
Hyderabad 5
Kunming 5
New Haven 5
Oxford 5
Phoenix 5
Vancouver 5
Washington 5
Atlanta 4
Barcelona 4
Belgrade 4
Bethesda 4
Clemmons 4
Düsseldorf 4
Fremont 4
Hamburg 4
Hebei 4
Kansas City 4
Las Vegas 4
Lyon 4
Mumbai 4
Nanchang 4
North Wales 4
Shinjuku 4
Vienna 4
Aarhus 3
Basel 3
Totale 2.204
Salva come PNG Salva come JPEG
Nome #
PARP inhibitors: an interesting pathway also for non-small cell lung cancer? 731
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial 643
Extending survival of stage IV non-small cell lung cancer. 512
Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors. 292
Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report 259
Fetal adenocarcinoma of the lung in a 25-year-old woman 133
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion 105
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease 83
Actuality and perspective in the medical treatment of non-small cell lung cancer [Article@Attualità e prospettive nella terapia medica del carcinoma polmonare non-a piccole cellule] 75
Early Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography. 74
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine. 72
Women with synchronous or metachronous lung and ovarian cancer: A multi-institutional report 70
Clinical meta-analyses of targeted therapies in adenocarcinoma 68
Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review 65
ATTUALITÀ SULLO SCREENING DEL TUMORE POLMONARE CON TOMOGRAFIA COMPUTERIZZATA SPIRALE A BASSA DOSE. 64
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas 63
Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: A review of existing evidence. 62
Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy 59
Clinical Implications and Added Costs of Incidental Findings in an Early Detection Study of Lung Cancer by Using Low-Dose Spiral Computed Tomography. 58
Low-dose spiral computer tomography screening for lung cancer [Article@Attualità sullo screening del tumore polmonare con tomografia computerizzata spirale a bassa dose] 54
Five-years results of a non-randomised study evaluating spiral computed tomography (sCT) for early detection of lung cancer (LC): PD1-1-5 50
Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? 49
TOWARD THERAPIES TAILORED TO PATIENT CHARACTERISTICS. 45
Primary Pleuropulmonary Sarcoma: A Rare Disease Entity. 45
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. 43
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 42
Lung cancer in never smokers: a different disease 40
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics 37
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers 30
Primary pleuropulmonary sarcoma: what we know about it? 28
MET inhibition in lung cancer 27
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey 20
Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey 11
Histological transformation to small cell lung carcinoma in non-small cell lung tumours oncogene and non-oncogene addicted. Clinical and biological features from an international cohort of patients 5
Totale 4.014
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020485 0 0 0 69 47 62 58 62 70 43 48 26
2020/2021645 30 49 50 81 81 40 61 44 25 52 55 77
2021/2022431 18 36 28 39 32 13 33 32 18 27 88 67
2022/2023556 65 29 8 68 57 120 64 34 65 18 20 8
2023/2024278 39 54 17 22 15 22 15 17 3 19 23 32
2024/2025136 13 74 34 15 0 0 0 0 0 0 0 0
Totale 4.014